Evidence map›Paper›PMID 27713932›Full record

ArticleACS omega2016

Label-Free Isothermal Amplification Assay for Specific and Highly Sensitive Colorimetric miRNA Detection.

Stefano Persano, Maria L Guevara, Joy Wolfram, Elvin Blanco, Haifa Shen, Mauro Ferrari, Pier Paolo Pompa

Abstract read
In one paragraph

Article in ACS omega, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Research advances in the detection of miRNA.Journal of pharmaceutical analysis · 2019
    Review
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Stefano PersanoDepartment of Nanomedicine, Houston Methodist Research Institute, 6670 Bertner Avenue, Houston 77030, Texas, United States; Istituto Italiano di Tecnologia (IIT), Via Morego, 30, 16163 Genova, Italy; Università del Salento, Via Provinciale Monteroni, 73100 Lecce, Italy.
Maria L GuevaraDepartment of Nanomedicine, Houston Methodist Research Institute , 6670 Bertner Avenue, Houston 77030, Texas, United States.
Joy WolframDepartment of Nanomedicine, Houston Methodist Research Institute , 6670 Bertner Avenue, Houston 77030, Texas, United States.
Elvin BlancoDepartment of Nanomedicine, Houston Methodist Research Institute , 6670 Bertner Avenue, Houston 77030, Texas, United States.
Haifa ShenDepartment of Nanomedicine, Houston Methodist Research Institute, 6670 Bertner Avenue, Houston 77030, Texas, United States; Department of Cell and Developmental Biology and Department of Medicine, Weill Cornell Medicine, 1330 York Avenue, New York 10065, New York, United States.
Mauro FerrariDepartment of Nanomedicine, Houston Methodist Research Institute, 6670 Bertner Avenue, Houston 77030, Texas, United States; Department of Cell and Developmental Biology and Department of Medicine, Weill Cornell Medicine, 1330 York Avenue, New York 10065, New York, United States.
Pier Paolo PompaIstituto Italiano di Tecnologia (IIT) , Via Morego, 30, 16163 Genova, Italy.

Funding

Texas Center for Cancer NanomedicineU54CA151668 · NCI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI FERRARI, MAURO · 2010 to 2014
$12.4M
TRANS-NETWORK PROJECTSU54CA143837 · NCI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI FERRARI, MAURO · 2009 to 2014
$10.8M
NCI NIH HHS U54 CA143837NCI NIH HHS U54 CA151668
6 · The paper itself

Abstract

We describe a new method for the detection of miRNA in biological samples. This technology is based on the isothermal nicking enzyme amplification reaction and subsequent hybridization of the amplification product with gold nanoparticles and magnetic microparticles (barcode system) to achieve naked-eye colorimetric detection. This platform was used to detect a specific miRNA (miRNA-10b) associated with breast cancer, and attomolar sensitivity was demonstrated. The assay was validated in cell culture lysates from breast cancer cells and in serum from a mouse model of breast cancer.

Identifiers

PMID27713932
PMCPMC5046170

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.